# Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System

> **NCT05293639** · NA · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 362 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Pulse Field Ablation

## Key facts

- **NCT ID:** NCT05293639
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-18
- **Primary completion:** 2023-12-11
- **Final completion:** 2023-12-11
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05293639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05293639, "Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT05293639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*